Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer

Fig. 3

The median riskScores and survival outcome of the low- and high-risk groups. A The median riskScores of low- and high-risk groups. B The survival outcome of low- and high-risk groups. C High-risk GC patients reveal worse survival compared to low-risk patients. D Univariate Cox regression shows that the risk model has a significant association with overall survival. E Multivariate Cox regression demonstrates the risk model as an independent prognostic indicator of poor outcome in GC

Back to article page